• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超重和肥胖的复方激素避孕药使用者的避孕失败。

Contraceptive failures in overweight and obese combined hormonal contraceptive users.

机构信息

Division of Clinical Research, Department of Obstetrics and Gynecology, Washington University in St. Louis School of Medicine, St. Louis, Missouri.

出版信息

Obstet Gynecol. 2013 Mar;121(3):585-592. doi: 10.1097/AOG.0b013e31828317cc.

DOI:10.1097/AOG.0b013e31828317cc
PMID:23635622
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4009704/
Abstract

OBJECTIVE

To estimate weather contraceptive failure rates among combined oral contraceptive pill (OCP), patch, and vaginal ring users was associated with increasing body mass index (BMI).

METHODS

Females enrolled in a large contraceptive study offering the reversible method of their choice at no cost were followed-up for 2-3 years. We compared the failure rates (pregnancy) among users of the OCP, transdermal patch, and contraceptive vaginal ring stratified by BMI.

RESULTS

Among the 7,486 participants available for this analysis, 1,523 chose OCPs, patch, or ring at enrollment. Of the 334 unintended pregnancies, 128 were found to be a result of OCP, patch, or ring failure. Three-year failure rates were not different across BMI categories (BMI less than 25 8.44%, 95% confidence interval [CI] 6.1-11.5; BMI 25-30 11.03%, 95% CI 7.5-16.0; BMI more than 30 8.92%, 95% confidence interval 7.6-11.5). Increasing parity (hazard ratio [HR] 3.06, CI 1.31-7.18) and history of a previous unintended pregnancy (HR 2.82, CI 1.63-4.87), but not BMI, were significant risk factors for unintended pregnancy.

CONCLUSION

Overweight and obese females do not appear to be at increased risk for contraceptive failure when using the OCP, patch, or vaginal ring.

摘要

目的

评估体重指数(BMI)升高与复方口服避孕药(OCP)、贴剂和阴道环使用者的避孕失败率之间的关系。

方法

在一项大型避孕研究中,选择了可免费提供的可逆避孕方法的女性入组,并随访 2-3 年。我们比较了 OCP、经皮贴剂和避孕阴道环使用者的避孕失败率(妊娠),并按 BMI 分层。

结果

在可用于此分析的 7486 名参与者中,有 1523 名在入组时选择了 OCP、贴剂或环。在 334 例意外妊娠中,有 128 例是由于 OCP、贴剂或环失败所致。三年失败率在 BMI 类别之间没有差异(BMI<25 为 8.44%,95%置信区间[CI]为 6.1-11.5;BMI 25-30 为 11.03%,95%CI 为 7.5-16.0;BMI>30 为 8.92%,95%CI 为 7.6-11.5)。增加的产次(危险比[HR]3.06,95%CI 1.31-7.18)和既往意外妊娠史(HR 2.82,95%CI 1.63-4.87)是意外妊娠的显著危险因素,但 BMI 不是。

结论

超重和肥胖女性使用 OCP、贴剂或阴道环时,似乎不会增加避孕失败的风险。

相似文献

1
Contraceptive failures in overweight and obese combined hormonal contraceptive users.超重和肥胖的复方激素避孕药使用者的避孕失败。
Obstet Gynecol. 2013 Mar;121(3):585-592. doi: 10.1097/AOG.0b013e31828317cc.
2
Hormonal contraceptives for contraception in overweight or obese women.超重或肥胖女性避孕用激素避孕药。
Cochrane Database Syst Rev. 2013 Apr 30(4):CD008452. doi: 10.1002/14651858.CD008452.pub3.
3
Hormonal contraceptives for contraception in overweight or obese women.超重或肥胖女性避孕用激素避孕药
Cochrane Database Syst Rev. 2016 Aug 18;2016(8):CD008452. doi: 10.1002/14651858.CD008452.pub4.
4
Combined hormonal contraceptive (CHC) use among obese women and contraceptive effectiveness: a systematic review.肥胖女性使用复方激素避孕药(CHC)与避孕效果:一项系统综述。
Contraception. 2017 Feb;95(2):117-129. doi: 10.1016/j.contraception.2016.10.010. Epub 2016 Nov 4.
5
Hormonal contraceptives for contraception in overweight or obese women.超重或肥胖女性避孕用激素避孕药。
Cochrane Database Syst Rev. 2010 Jul 7(7):CD008452. doi: 10.1002/14651858.CD008452.pub2.
6
Contraceptive failures in overweight and obese combined hormonal contraceptive users.超重和肥胖的复方激素避孕药使用者的避孕失败情况。
Obstet Gynecol. 2013 Jul;122(1):158-159. doi: 10.1097/AOG.0b013e3182995811.
7
Effectiveness of long-acting reversible contraception.长效可逆避孕措施的效果。
N Engl J Med. 2012 May 24;366(21):1998-2007. doi: 10.1056/NEJMoa1110855.
8
Association between tampon use and choosing the contraceptive vaginal ring.卫生棉条使用与选择避孕阴道环之间的关联。
Obstet Gynecol. 2010 Apr;115(4):735-739. doi: 10.1097/AOG.0b013e3181d41c4a.
9
Pregnancy Intention and Contraceptive Use among Women by Class of Obesity: Results from the 2006-2010 and 2011-2013 National Survey of Family Growth.肥胖程度不同的女性的妊娠意向和避孕措施使用情况:来自 2006-2010 年和 2011-2013 年全国家庭增长调查的结果。
Womens Health Issues. 2018 Jan-Feb;28(1):51-58. doi: 10.1016/j.whi.2017.09.010. Epub 2017 Nov 13.
10
Factors associated with 12-month discontinuation among contraceptive pill, patch, and ring users.与避孕药、贴片和环使用者 12 个月停药相关的因素。
Obstet Gynecol. 2013 Feb;121(2 Pt 1):330-336. doi: 10.1097/AOG.0b013e31827e5898.

引用本文的文献

1
Reproductive Planning and the Choice of Long-acting Reversible Contraceptive Primary to Health: A Cross-Sectional Study.生殖计划与长效可逆避孕选择:以健康为首要考虑的横断面研究。
Rev Bras Ginecol Obstet. 2023 Aug;45(8):e456-e464. doi: 10.1055/s-0043-1772188. Epub 2023 Sep 8.
2
Contraceptive Options Following Gestational Diabetes: Current Perspectives.妊娠期糖尿病后的避孕选择:当前观点
Open Access J Contracept. 2019 Oct 22;10:41-53. doi: 10.2147/OAJC.S184821. eCollection 2019.
3
Altered pharmacokinetics of combined oral contraceptives in obesity - multistudy assessment.

本文引用的文献

1
Structured contraceptive counseling provided by the Contraceptive CHOICE Project.计划生育 CHOICE 项目提供的结构化避孕咨询。
Contraception. 2013 Aug;88(2):243-9. doi: 10.1016/j.contraception.2012.07.015. Epub 2012 Sep 5.
2
Does obesity really matter? The impact of BMI on embryo quality and pregnancy outcomes after IVF in women aged ≤38 years.肥胖真的有关系吗?体重指数对38岁及以下女性体外受精后胚胎质量和妊娠结局的影响。
Aust N Z J Obstet Gynaecol. 2012 Jun;52(3):270-6. doi: 10.1111/j.1479-828X.2012.01453.x.
3
Effectiveness of long-acting reversible contraception.
肥胖患者中复方口服避孕药的药代动力学改变 - 多研究评估。
Contraception. 2019 Apr;99(4):256-263. doi: 10.1016/j.contraception.2018.12.009. Epub 2019 Jan 23.
4
Consensus Statement on the Use of Oral Contraceptive Pills in Polycystic Ovarian Syndrome Women in India.印度多囊卵巢综合征女性口服避孕药使用的共识声明。
J Hum Reprod Sci. 2018 Apr-Jun;11(2):96-118. doi: 10.4103/jhrs.JHRS_72_18.
5
Transdermal delivery of combined hormonal contraception: a review of the current literature.复方激素避孕的经皮给药:当前文献综述
Int J Womens Health. 2017 May 15;9:315-321. doi: 10.2147/IJWH.S102306. eCollection 2017.
6
Healthcare Provider Attitudes Regarding Contraception for Women with Obesity.医疗服务提供者对肥胖女性避孕的态度。
J Womens Health (Larchmt). 2017 Aug;26(8):870-877. doi: 10.1089/jwh.2016.5930. Epub 2017 Jan 31.
7
Clarification of contraceptive drug pharmacokinetics in obesity.肥胖人群中避孕药药代动力学的阐释
Contraception. 2017 Jan;95(1):10-16. doi: 10.1016/j.contraception.2016.08.003. Epub 2016 Aug 16.
8
Hormonal contraceptives for contraception in overweight or obese women.超重或肥胖女性避孕用激素避孕药
Cochrane Database Syst Rev. 2016 Aug 18;2016(8):CD008452. doi: 10.1002/14651858.CD008452.pub4.
9
How can we improve oral contraceptive success in obese women?我们如何提高肥胖女性口服避孕药的成功率?
Expert Rev Clin Pharmacol. 2015 Jan;8(1):1-3. doi: 10.1586/17512433.2015.974558. Epub 2014 Oct 29.
10
The contraceptive CHOICE project round up: what we did and what we learned.避孕选择项目综述:我们所做的及所学到的。
Clin Obstet Gynecol. 2014 Dec;57(4):635-43. doi: 10.1097/GRF.0000000000000070.
长效可逆避孕措施的效果。
N Engl J Med. 2012 May 24;366(21):1998-2007. doi: 10.1056/NEJMoa1110855.
4
Body mass index and short-term weight change in relation to treatment outcomes in women undergoing assisted reproduction.体重指数和短期体重变化与接受辅助生殖治疗的女性的治疗结局的关系。
Fertil Steril. 2012 Jul;98(1):109-16. doi: 10.1016/j.fertnstert.2012.04.012. Epub 2012 May 16.
5
Contribution of overweight and obesity to the occurrence of adverse pregnancy outcomes in a multi-ethnic cohort: population attributive fractions for Amsterdam.超重和肥胖对多民族队列不良妊娠结局发生的影响:阿姆斯特丹人群归因分数。
BJOG. 2012 Feb;119(3):283-90. doi: 10.1111/j.1471-0528.2011.03205.x. Epub 2011 Dec 13.
6
Body weight does not impact pregnancy rates during use of a low-dose extended-regimen 91-day oral contraceptive.体重不会影响使用低剂量延长方案的 91 天口服避孕药的妊娠率。
Contraception. 2012 Mar;85(3):235-9. doi: 10.1016/j.contraception.2011.08.001. Epub 2011 Sep 19.
7
Unintended pregnancy in the United States: incidence and disparities, 2006.美国意外妊娠:发生率和差异,2006 年。
Contraception. 2011 Nov;84(5):478-85. doi: 10.1016/j.contraception.2011.07.013. Epub 2011 Aug 24.
8
Pre-pregnancy and pregnancy obesity and neurodevelopmental outcomes in offspring: a systematic review.孕前和孕期肥胖与后代神经发育结局:系统评价。
Obes Rev. 2011 May;12(5):e548-59. doi: 10.1111/j.1467-789X.2010.00850.x. Epub 2011 Mar 17.
9
Overweight and obesity in pregnancy do not adversely affect neonatal outcomes: new evidence.孕期超重和肥胖不会对新生儿结局产生不利影响:新证据。
J Obstet Gynaecol. 2010;30(7):679-86. doi: 10.3109/01443615.2010.509824.
10
Ovarian suppression in normal-weight and obese women during oral contraceptive use: a randomized controlled trial.正常体重和肥胖女性在口服避孕药使用期间的卵巢抑制:一项随机对照试验。
Obstet Gynecol. 2010 Aug;116(2 Pt 1):275-283. doi: 10.1097/AOG.0b013e3181e79440.